Cocaine use is associated with an increased risk of stent thrombosis after percutaneous coronary intervention

American Heart Journal

Volumn 154, Issue 1, 2007, Pages 159-164

  McKee, Scott A ^a   Applegate, Robert J ^a   Hoyle, John R ^a   Sacrinty, Matthew T ^a   Kutcher, Michael A ^a   Sane, David C ^a  

^a WAKE FOREST SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE CORONARY SYNDROME; ADULT; AGED; ARTICLE; COCAINE DEPENDENCE; CONTROLLED STUDY; CORONARY ARTERY THROMBOSIS; CORONARY RISK; CORONARY STENT; FEMALE; FOLLOW UP; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RETREATMENT; TREATMENT OUTCOME;

ANGIOPLASTY, BALLOON; CAUSALITY; COCAINE; COCAINE-RELATED DISORDERS; COMORBIDITY; FEMALE; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; RISK FACTORS; STENTS; SURVIVAL RATE; THROMBOSIS;

EID: 34250358625     PISSN: 00028703     EISSN: 10976744     Source Type: Journal    
DOI: 10.1016/j.ahj.2007.04.004     Document Type: Article

References (23)

1. Coleman D.L., Ross T.F., and Naughton J.L. Myocardial ischemia and infarction related to recreational cocaine use. West J Med 136 (1982) 444-446
2. Minor Jr. R.L., Scott B.D., Brown D.D., et al. Cocaine-induced myocardial infarction in patients with normal coronary arteries. Ann Intern Med 115 (1991) 797-806
3. Caravati E.M., and Ling L.J. Toxicology education in emergency medicine residency programs. J Emerg Med 10 (1992) 169-177
4. Pitts W.R., Lange R.A., Cigarroa J.E., et al. Cocaine-induced myocardial ischemia and infarction: pathophysiology, recognition, and management. Prog Cardiovasc Dis 40 (1997) 65-76
5. www.whitehousedrugpolicy.gov/publications/factsht/druguse/index.html
6. Brogan III W.C., Lange R.A., Kim A.S., et al. Alleviation of cocaine-induced coronary vasoconstriction by nitroglycerin. J Am Coll Cardiol 18 (1991) 581-586
7. Negus B.H., Willard J.E., Hillis L.D., et al. Alleviation of cocaine-induced coronary vasoconstriction with intravenous verapamil. Am J Cardiol 73 (1994) 510-513
8. Hollander J.E., Burstein J.L., Hoffman R.S., et al. Cocaine-associated myocardial infarction. Clinical safety of thrombolytic therapy. Cocaine Associated Myocardial Infarction (CAMI) Study Group. Chest 107 (1995) 1237-1241
9. Lange R.A., and Hillis L.D. Cardiovascular complications of cocaine use. N Engl J Med 345 (2001) 351-358
10. Shah D.M., Dy T.C., Szto G.Y., et al. Percutaneous transluminal coronary angioplasty and stenting for cocaine-induced acute myocardial infarction: a case report and review. Catheter Cardiovasc Interv 49 (2000) 447-451
11. Sharma A.K., Hamwi S.M., Garg N., et al. Percutaneous interventions in patients with cocaine-associated myocardial infarction: a case series and review. Catheter Cardiovasc Interv 56 (2002) 346-352
12. Braunwald E., Antman E.M., Beasley J.W., et al. ACC/AHA guidelines for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients with Unstable Angina). J Am Coll Cardiol 40 (2002) 1366-1374
13. Applegate R.J., Sacrinty M.T., Kutcher M.A., et al. Comparison of drug-eluting versus bare metal stents on later frequency of acute myocardial infarction and death. Am J Cardiol 99 (2007) 333-338
14. D'Agostino R.B. Tutorial in biostatistics-propensity score methods for bias reduction in the comparison of a treatment to a non-randomized control group. Stat Med 17 (1998) 2265-2281
15. Blackstone E.H. Comparing apples and oranges. J Thorac Cardiovasc Surg 123 (2002) 8-15
16. Parsons L.S. Reducing bias in a propensity score matched-pair sample using greedy matching techniques. Proceedings of the Twenty-Sixth Annual SAS Users Group International Conference. Cary, NC SAS Institute Inc (2001)
17. Heesch C.M., Wilhelm C.R., Ristich J., et al. Cocaine activates platelets and increases the formation of circulating platelet containing microaggregates in humans. Heart 83 (2000) 688-695
18. Benzaquen B.S., Cohen V., and Eisenberg M.J. Effects of cocaine on the coronary arteries. Am Heart J 142 (2001) 402-410
19. Kugelmass A.D., Oda A., Monahan K., et al. Activation of human platelets by cocaine. Circulation 88 (1993) 876-883
20. Ho M.P., Spertus J.A., Masoudi F.A., et al. Impact of medication therapy discontinuation on mortality after myocardial infarction. Arch Intern Med 166 (2006) 1842-1847
21. Spertus J.A., Kettelkamp R., Vance C., et al. Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry. Circulation 113 (2006) 2803-2809
22. Boen W.E., O'Rourke R.A., Crawford M.H., et al. Outcomes in patients with acute non-Q-wave myocardial infarction randomly assigned to an invasive as compared with a conservative management strategy. Veterans Affairs Non-Q-Wave Infarctoin Strategies in Hospital (VANQWISH) Trial investigators. N Engl J Med 338 (1998) 1785-1792
23. Wallentin L., and for the Fragmin and Fast Revascularization during InStability in Coronary artery disease Investigators. Invasive compared with non-invasive treatment in unstable coronary-artery diesease: FRISC II prospective randomised multicentre study. Lancet 354 (1999) 708-715